Tobacco use, sales and prices: a European perspective
Tendances n° 126, OFDT, 6 p.
July 2018
The objective of this issue is to offer a glimpse into tobacco use in Western countries, using prevalence surveys, annual data on tobacco sales and average tobacco prices.
This is a complex undertaking as no international surveys have been conducted with a view to determining the prevalence of tobacco smoking in the population of each of these countries over the same year and, in particular, there have been no studies on current prices. Hence, comparison is only possible based on limited national or supranational surveys, not necessarily taking place over the same period or using the same methodology.
This Tendances thus brings these various data together, notably in the form of maps, to offer a comparison between the various countries and to put the situation in France into perspective.
Author : Aurélie Lermenier-Jeannet
Download the PDF file (2,47 Mo)
Drugs in Europe
2023 EMCDDA European Drug Report
The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions. This report is based on information provided to the EMCDDA by the EU Member States, the candidate country Türkiye, and Norway, in an annual reporting process.
The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.